These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21167338)

  • 21. PCI versus CABG versus medical therapy in 2006.
    Morrison D
    Minerva Cardioangiol; 2006 Oct; 54(5):643-72. PubMed ID: 17019400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).
    Rashba EJ; Lamas GA; Couderc JP; Hollist SM; Dzavik V; Ruzyllo W; Fridrich V; Buller CE; Forman SA; Kufera JA; Carvalho AC; Hochman JS;
    Circulation; 2009 Feb; 119(6):779-87. PubMed ID: 19188505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Fokkema ML; James SK; Albertsson P; Aasa M; Åkerblom A; Calais F; Eriksson P; Jensen J; Schersten F; de Smet BJ; Sjögren I; Tornvall P; Lagerqvist B
    EuroIntervention; 2016 Jun; 12(3):303-11. PubMed ID: 26485732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial.
    Steg PG; Kerner A; Mancini GB; Reynolds HR; Carvalho AC; Fridrich V; White HD; Forman SA; Lamas GA; Hochman JS; Buller CE;
    Circulation; 2010 Jun; 121(25):2724-30. PubMed ID: 20547926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
    Buller CE; Rankin JM; Carere RG; Buszman PE; Pfisterer ME; Dzavik V; Thomas B; Forman S; Ruzyllo W; Mancini GB; Michalis LK; Abreu PF; Lamas GA; Hochman JS
    Am Heart J; 2009 Sep; 158(3):408-15. PubMed ID: 19699864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
    Gershlick AH; Khan JN; Kelly DJ; Greenwood JP; Sasikaran T; Curzen N; Blackman DJ; Dalby M; Fairbrother KL; Banya W; Wang D; Flather M; Hetherington SL; Kelion AD; Talwar S; Gunning M; Hall R; Swanton H; McCann GP
    J Am Coll Cardiol; 2015 Mar; 65(10):963-72. PubMed ID: 25766941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of stenting and surgical revascularization strategy in non-ST elevation acute coronary syndromes and complex coronary artery disease (from the Milestone Registry).
    Buszman PE; Buszman PP; Bochenek A; Gierlotka M; Gąsior M; Milewski K; Orlik B; Janas A; Wojakowski W; Kiesz RS; Zembala M; Poloński L
    Am J Cardiol; 2014 Oct; 114(7):979-87. PubMed ID: 25124186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postprocedural anticoagulation for specific therapeutic indications after revascularization for ST-segment elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial).
    Madhavan MV; Généreux P; Kirtane AJ; Xu K; Witzenbichler B; Mehran R; Stone GW
    Am J Cardiol; 2014 Nov; 114(9):1322-8. PubMed ID: 25239828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT).
    Malek LA; Reynolds HR; Forman SA; Vozzi C; Mancini GB; French JK; Dziarmaga M; Renkin JP; Kochman J; Lamas GA; Hochman JS
    Am Heart J; 2009 Apr; 157(4):724-32. PubMed ID: 19332202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
    Kim MC; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Cho SY; Rha SW; Bae JH; Cho JG; Park SJ;
    Int J Cardiol; 2011 Dec; 153(2):148-53. PubMed ID: 20843572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [12-month outcomes of percutaneous and surgical revascularization in acute coronary syndromes without ST-segment elevation in patients with multivessel coronary artery disease].
    Szyguła-Jurkewicz B; Wilczek K; Gorzkowska A; Niklewski T; Zembala M; Poloński L
    Pol Arch Med Wewn; 2005 Jan; 113(1):56-62. PubMed ID: 16130602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
    Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.
    Qintar M; Humphries KH; Park JE; Arnold SV; Tang Y; Jones P; Salisbury AC; Kureshi F; Farkouh ME; Fuster V; Cohen DJ; Spertus JA
    J Am Coll Cardiol; 2019 Oct; 74(16):2074-2084. PubMed ID: 31623766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).
    Jhaveri RR; Reynolds HR; Katz SD; Jeger R; Zinka E; Forman SA; Lamas GA; Hochman JS
    J Card Fail; 2012 Nov; 18(11):813-21. PubMed ID: 23141853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prognosis in stable angina; medical treatment or coronary revascularization in patients younger than 70 years?
    Carpeggiani C; Landi P; Michelassi C; Barberini E; L'Abbate A
    Int J Cardiol; 2011 Apr; 148(1):43-7. PubMed ID: 19913308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery.
    Wöhrle J; Brodie B; Witzenbichler B; Dudek D; Kornowski R; Metzger C; Grines C; McAndrew TC; Parise H; Sergie Z; Mehran R; Stone GW
    Am J Cardiol; 2013 Sep; 112(6):753-60. PubMed ID: 23746479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.